chr3-37017508-C-G
Variant summary
The NM_000249.4(MLH1):c.793C>G (p.Arg265Gly) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 7.28). Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV001363159: Internal RNA analysis reports experimental evidence that this variant affects mRNA splicing resulting in skipping of exon 10 and exon 10-11 in a smaller proportion of transcripts, each of which would result in an out-of frame outcome (internal data)." and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R265V: Pathogenic (ClinVar VariationId 619508, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R265H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 90381, 1 star); p.R265L: Uncertain_significance (ClinVar VariationId 1928288, 2 stars); p.R265= (synonymous): Likely_benign (ClinVar VariationId 491730, 2 stars)
Frequency
Consequence
NM_000249.4 missense, splice_region
Predictors
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Genomics England PanelApp
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 19 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV001363159: Internal RNA analysis reports experimental evidence that this variant affects mRNA splicing resulting in skipping of exon 10 and exon 10-11 in a smaller proportion of transcripts, each of which would result in an out-of frame outcome (internal data).; SCV002676419: Another alteration at the same codon, p.R265S (c.793C>A), has been identified in multiple individuals with Lynch/HNPCC-related cancers (Zavodna K et al. Neoplasma. 2006;53:269-76; Alemayehu A et al. Genes Chromosomes Cancer. 2008 Oct;47:906-14; Hardt K et al. Fam. Cancer. 2011 Jun;10:273-84; Ferguson SE et al. Cancer. 2014 Dec;120:3932-9), and has been shown to be deleterious in several functional assays (Wanat JJ et al. Hum. Mol. Genet. 2007 Feb;16:445-52; Drost M et al. Hum. Mutat. 2010 Mar;31:247-53; van der Klift HM et al. Mol Genet Genomic Med. 2015 Jul;3:327-45; Soukarieh O et al. PLoS Genet. 2016 Jan;12:e1005756).; SCV003786423: RNA analysis indicates that this missense change induces altered splicing and may result in an absent or altered protein product. Studies have shown that this missense change results in skipping of exon 10, and produces a non-functional protein and/or introduces a premature termination codon (internal data). | ||
| PS4Prevalence increased in affected individuals | Rare variant reported in affected individuals by ≥2 independent ClinVar submitters (PS4_Supporting); 4 ClinVar submitter(s) report the variant in affected individuals; SCV001134323: The MLH1 c.793C>G (p.Arg265Gly) variant has been reported in the published literature in individuals with colorectal cancer where tumors showed microsatellite instability and loss of MLH1 and PMS2 protein expression on immunohistochemistry (PMID: 31101557 (2019), personal communication with Ambry Genetics regarding ClinVar ID: 801205). The variant has also been identified as a somatic variant in individuals with colorectal cancer (PMIDs: 25111426 (2014) and 39109916 (2024)).; SCV001363159: The variant was absent in 251460 control chromosomes. c.793C>G has been reported in the literature in individuals affected with Lynch Syndrome/Hereditary Nonpolyposis Colorectal Cancer (example, Mork_2019, Feng_2024).; SCV002676419: This variant has been identified in multiple families diagnosed with Lynch syndrome (Mork ME et al. Cancer Genet. 2019 06;235-236:77-83; Ambry internal data).This variant has been identified in a proband(s) whose Lynch syndrome-associated tumor demonstrated loss of MLH1 and PMS2 expression by immunohistochemistry (Ambry internal data).; SCV003786423: This missense change has been observed in individual(s) with colorectal cancer (PMID: 31101557). | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants; ±8 AA neighbourhood: 3 pathogenic, 3 benign (OR vs. background: 5.0) | ||
| PM2Absent/extremely low in population databases | Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (base 0.0001, raised to 0.0005 by highest known P/LP ClinVar AF 0.000636) — PM2 moderate | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R265V: Pathogenic (ClinVar VariationId 619508, 1 star); Other variants at the same amino acid residue (not pathogenic): p.R265H: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 90381, 1 star); p.R265L: Uncertain_significance (ClinVar VariationId 1928288, 2 stars); p.R265= (synonymous): Likely_benign (ClinVar VariationId 491730, 2 stars) | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — strong evidence (PP3); Splicing verdict: not pathogenic; Germline computational verdict: pathogenic (Strong) | ||
| PP5Reputable source reports pathogenic | ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MLH1 | MANE Select | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 19 | Prot: NP_000240.1 | |
MLH1 | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 18 | Prot: NP_001341557.1 | ||
MLH1 | c.694C>G p.Arg232Gly | missensesplice_region | Exon 9 of 18 | Prot: NP_001341558.1 |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MLH1 | MANE Select | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 19 | Prot: ENSP00000231790 | |
MLH1 | TSL:1 | c.70C>G p.Arg24Gly | missensesplice_region | Exon 11 of 20 | Prot: ENSP00000402667 | |
MLH1 | c.793C>G p.Arg265Gly | missensesplice_region | Exon 10 of 19 | Prot: ENSP00000601248 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:31 | ||||
GnomAD4 genome | Cov:32 | ||||
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 34 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.59 | |
CADD | Pathogenic | 31 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.90 | D |
Eigen | Pathogenic | 1.1 | |
Eigen_PC | Pathogenic | 1.0 | |
FATHMM_MKL | Pathogenic | 1.0 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -9.7 | |
GPN-Star score | N/A | 9.7 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.79 | D |
MetaRNN | Pathogenic | 0.96 | D |
MetaSVM | Pathogenic | 0.94 | D |
Mutation Taster | N/A | 0/100 | disease causing |
MutationAssessor | Pathogenic | 4.8 | H |
PhyloP100 | Uncertain | 7.3 | |
popEVE | Benign | -4.1 | |
PrimateAI | Uncertain | 0.65 | T |
PROVEAN | Pathogenic | -7.0 | D |
REVEL | Pathogenic | 0.96 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.99 | |
VESM-3B | Benign | -15 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Uncertain | 0.31 | |
Pangolin loss | Uncertain | 0.31 | Position offset: -2 |
SpliceAI score (max) | Benign | 0.16 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.